Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03768466
Recruitment Status : Recruiting
First Posted : December 7, 2018
Last Update Posted : April 24, 2019
Sponsor:
Information provided by (Responsible Party):
Mundipharma Korea Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : April 2020